CS
The startup provides RNA sequencing tests specifically designed for the identification of tick-borne pathogens. By delivering precise pathogen detection, the tests enable timely and accurate treatment, reducing the risk of disease progression and long-term health complications.
Updated 3 months ago
Funding
$2.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup provides RNA sequencing tests specifically designed for the identification of tick-borne pathogens. By delivering precise pathogen detection, the tests enable timely and accurate treatment, reducing the risk of disease progression and long-term health complications.